河车大造胶囊对肿瘤化疗药增效作用的研究

Study on Synergy of“He Che Da Zao Capsule”on Chemotherapeutic Drugs in Tumor

本研究应用河车大造胶囊对肿瘤化疗药治疗187例原发性肺癌和恶性淋巴瘤增效作用进行评价。结果表明,河车大造胶囊对原发性肺癌51例的总缓解率为54.9％,明显优于23例阳性药十全大补胶囊对照组的39.1％,及单纯化疗药组20例的35％。河车大造胶囊对恶性淋巴瘤52例的总缓解率为86.54％,也明显优于20例十全大补胶囊组的65％、单纯化疗组21例的61％。同时河车大造胶囊可减缓化疗药的毒副作用,保护造血功能、免疫功能等作用。因此认为该药为目前理想的肿瘤化疗药增效药物。

The synergy of 'He Che Da Zao capsule' on Chemotherapeutic drugs in treating 187 cases of primary lung cancer and malignant lymphoma was assessed in this article. The result showed that; the total relieving rate of 51cases of primary lung cancer treated with 'He Che Da Zao cap- sule' (54. 9%) was obviously superior to that of the control group of 23 cases treated with 'Shi Quan Da Bu capsule' (39. 1%). The total relieving rate of 52 cases of malignant lymphoma (86.54%) was also obviously superior to that of 20 cases treated with 'Shi Quan Da Bu capsule' (65%) and to that of 21 cases of siniple-chemotherapeutic group (61%). At the same time, the 'He Che Da Zao capsule 'might relieve toxic and side effect of Chemotherapeutic drugs, and protect hematopoietic and immune function.